{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,27]],"date-time":"2026-10-27T22:11:16Z","timestamp":1793139076333,"version":"4.5.0"},"reference-count":96,"publisher":"Frontiers Media SA","license":[{"start":{"date-parts":[[2026,8,27]],"date-time":"2026-08-27T00:00:00Z","timestamp":1787788800000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"content-domain":{"domain":["frontiersin.org"],"crossmark-restriction":true},"short-container-title":["Front. Cell Dev. Biol."],"abstract":"<jats:p>Alzheimer\u2019s disease (AD), the most prevalent cause of dementia, lacks definitive cures despite decades of research focused on amyloid-beta (A\u03b2) and tau pathologies. Emerging evidence positions mitochondrial dysfunction not merely as a downstream consequence, but as the epicenter linking aging, metabolic failure, and neuroinflammation in AD pathogenesis. This study synthesizes the latest advances in mitochondrial-targeted therapies, framing them within a \u201cMitochondrial Ecological Restoration\u201d perspective. I analyze the molecular mechanisms by which mitochondrial-targeted therapies modulate oxidative stress, mitochondrial dynamics, mitophagy and neuroinflammation, and evaluate their translational potential. Accumulating evidence indicates that strategies ranging from antioxidants (e.g., MitoQ) to mitophagy enhancement (e.g., Spautin-1) and biogenesis activation (e.g., PGC-1\u03b1 Activator) have demonstrated efficacy in preclinical models. These interventions theoretically interrupt the pathological cycle between proteotoxicity and bioenergetic crisis. While challenges in blood-brain barrier (BBB) penetration and target specificity persist, the field is shifting from single-target scavenging to combinatorial ecosystem repair. Future success will require precise delivery systems, early biomarkers, and a paradigm shift toward treating the neuron as a metabolic ecosystem, though substantial translational challenges remain.<\/jats:p>","DOI":"10.3389\/fcell.2026.1886145","type":"journal-article","created":{"date-parts":[[2026,8,27]],"date-time":"2026-08-27T11:02:41Z","timestamp":1787828561000},"update-policy":"https:\/\/doi.org\/10.3389\/crossmark-policy","source":"Crossref","is-referenced-by-count":1,"title":["Mitochondrial ecosystem restoration in Alzheimer\u2019s disease: from mechanisms to multi-target therapeutic strategies"],"prefix":"10.3389","volume":"14","author":[{"given":"Dandan","family":"Song","sequence":"first","affiliation":[{"name":"Department of Pharmacy, Shaoxing Seventh People\u2019s Hospital (Affiliated Mental Health Center, Shaoxing University)","place":["Shaoxing, China"]}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"1965","published-online":{"date-parts":[[2026,8,27]]},"reference":[{"key":"B1","doi-asserted-by":"publisher","first-page":"18","DOI":"10.3390\/ph18111731","article-title":"Targeting Amyloid-\u03b2 proteins as potential alzheimer's disease therapeutics: anti-amyloid drug discovery, emerging therapeutics, clinical trials and implications for public health","volume":"18","author":"Abduljawad","year":"2025","journal-title":"Pharm. (Basel)."},{"key":"B2","doi-asserted-by":"publisher","first-page":"29","DOI":"10.1007\/s12031-025-02324-9","article-title":"Insights into the therapeutic potential of SIRT1-modifying compounds for alzheimer's disease: a focus on molecular mechanisms","volume":"75","author":"AlHayani","year":"2025","journal-title":"J. Mol. Neurosci."},{"key":"B3","doi-asserted-by":"publisher","first-page":"4","DOI":"10.1111\/acel.12538","article-title":"Function of the SIRT3 mitochondrial deacetylase in cellular physiology, cancer, and neurodegenerative disease","volume":"16","author":"Ansari","year":"2017","journal-title":"Aging Cell"},{"key":"B4","doi-asserted-by":"publisher","first-page":"4491","DOI":"10.1093\/hmg\/ddv173","article-title":"Mitochondrial DNA variants can mediate methylation status of inflammation, angiogenesis and signaling genes","volume":"24","author":"Atilano","year":"2015","journal-title":"Hum. Mol. Genet."},{"key":"B5","doi-asserted-by":"publisher","first-page":"5099","DOI":"10.1523\/jneurosci.2385-16.2017","article-title":"Inhibition of Drp1 ameliorates synaptic depression, A\u03b2 deposition, and cognitive impairment in an alzheimer's disease model","volume":"37","author":"Baek","year":"2017","journal-title":"J. Neurosci."},{"key":"B6","doi-asserted-by":"publisher","first-page":"2421","DOI":"10.1038\/s41467-021-22624-z","article-title":"Generation of a humanized A\u03b2 expressing mouse demonstrating aspects of Alzheimer's disease-like pathology","volume":"12","author":"Baglietto-Vargas","year":"2021","journal-title":"Nat. Commun."},{"key":"B7","doi-asserted-by":"publisher","first-page":"110","DOI":"10.1097\/jcp.0b013e318160862c","article-title":"Six-month randomized, placebo-controlled, double-blind, pilot clinical trial of curcumin in patients with alzheimer disease","volume":"28","author":"Baum","year":"2008","journal-title":"J. Clin. Psychopharmacol."},{"key":"B8","doi-asserted-by":"publisher","first-page":"543","DOI":"10.1001\/jamaneurol.2014.131","article-title":"A randomized clinical trial of high-dosage coenzyme Q10 in early parkinson disease: no evidence of benefit","volume":"71","author":"Beal","year":"2014","journal-title":"JAMA Neurol."},{"key":"B9","doi-asserted-by":"publisher","first-page":"518","DOI":"10.1358\/dnp.2010.23.8.1500435","article-title":"The rise and fall of dimebon","volume":"23","author":"Bezprozvanny","year":"2010","journal-title":"Drug News Perspect."},{"key":"B10","doi-asserted-by":"publisher","first-page":"25","DOI":"10.3390\/molecules25245789","article-title":"Comprehensive review on alzheimer's disease: causes and treatment","volume":"25","author":"Breijyeh","year":"2020","journal-title":"Molecules"},{"key":"B11","doi-asserted-by":"publisher","first-page":"1322","DOI":"10.4103\/nrr.Nrr-d-24-01459","article-title":"Mitochondrial damage-associated molecular patterns: neuroimmunomodulators in central nervous system pathophysiology","volume":"21","author":"Brooks","year":"2026","journal-title":"Neural Regen. Res."},{"key":"B12","doi-asserted-by":"publisher","first-page":"145","DOI":"10.1152\/physrev.00030.2018","article-title":"SIRT6, a mammalian deacylase with multitasking abilities","volume":"100","author":"Chang","year":"2020","journal-title":"Physiol. Rev."},{"key":"B13","doi-asserted-by":"publisher","first-page":"129","DOI":"10.1186\/s12974-021-02187-y","article-title":"Early glycolytic reprogramming controls microglial inflammatory activation","volume":"18","author":"Cheng","year":"2021","journal-title":"J. Neuroinflammation"},{"key":"B14","doi-asserted-by":"publisher","first-page":"11","DOI":"10.3390\/biomedicines11092488","article-title":"Mitochondria and brain disease: a comprehensive review of pathological mechanisms and therapeutic opportunities","volume":"11","author":"Clemente-Su\u00e1rez","year":"2023","journal-title":"Biomedicines"},{"key":"B15","doi-asserted-by":"publisher","first-page":"37","DOI":"10.1186\/alzrt269","article-title":"Alzheimer's disease drug-development pipeline: few candidates, frequent failures","volume":"6","author":"Cummings","year":"2014","journal-title":"Alzheimers Res. Ther."},{"key":"B16","doi-asserted-by":"publisher","first-page":"e12295","DOI":"10.1002\/trc2.12295","article-title":"Alzheimer's disease drug development pipeline: 2022","volume":"8","author":"Cummings","year":"2022","journal-title":"Alzheimers Dement. (N Y)"},{"key":"B17","doi-asserted-by":"publisher","first-page":"e70098","DOI":"10.1002\/trc2.70098","article-title":"Alzheimer's disease drug development pipeline: 2025","volume":"11","author":"Cummings","year":"2025","journal-title":"Alzheimers Dement. (N Y)"},{"key":"B18","doi-asserted-by":"publisher","first-page":"102713","DOI":"10.1016\/j.arr.2025.102713","article-title":"Mitochondrial dysfunction in alzheimer's disease","volume":"107","author":"D'Alessandro","year":"2025","journal-title":"Ageing Res. Rev."},{"key":"B19","doi-asserted-by":"publisher","first-page":"13","DOI":"10.3390\/cells13010012","article-title":"Mitochondrial targeting against alzheimer's disease: lessons from hibernation","volume":"13","author":"de Veij Mestdagh","year":"2023","journal-title":"Cells"},{"key":"B20","doi-asserted-by":"publisher","first-page":"535","DOI":"10.1007\/s12035-021-02612-6","article-title":"Recent advances in molecular pathways and therapeutic implications targeting mitochondrial dysfunction for alzheimer's disease","volume":"59","author":"Dhapola","year":"2022","journal-title":"Mol. Neurobiol."},{"key":"B21","doi-asserted-by":"publisher","first-page":"13","DOI":"10.3390\/antiox13020191","article-title":"CoQ(10) and mitochondrial dysfunction in alzheimer's disease","volume":"13","author":"Fi\u0161ar","year":"2024","journal-title":"Antioxidants (Basel)"},{"key":"B22","doi-asserted-by":"publisher","first-page":"836","DOI":"10.1001\/archneurol.2012.85","article-title":"Antioxidants for alzheimer disease: a randomized clinical trial with cerebrospinal fluid biomarker measures","volume":"69","author":"Galasko","year":"2012","journal-title":"Arch. Neurol."},{"key":"B23","doi-asserted-by":"publisher","first-page":"5940","DOI":"10.1002\/alz.14044","article-title":"A functional aged human iPSC-cortical neuron model recapitulates alzheimer's disease, senescence, and the response to therapeutics","volume":"20","author":"Gallo","year":"2024","journal-title":"Alzheimers Dement."},{"key":"B24","doi-asserted-by":"publisher","first-page":"149796","DOI":"10.1016\/j.brainres.2025.149796","article-title":"Intermittent ELF-MF exposure effectively ameliorates pathologic features associated with adult AD mice","volume":"1864","author":"Geng","year":"2025","journal-title":"Brain Res."},{"key":"B25","doi-asserted-by":"publisher","first-page":"1581","DOI":"10.1016\/j.neurobiolaging.2012.12.005","article-title":"Nicotinamide riboside restores cognition through an upregulation of proliferator-activated receptor-\u03b3 coactivator 1\u03b1 regulated \u03b2-secretase 1 degradation and mitochondrial gene expression in Alzheimer's mouse models","volume":"34","author":"Gong","year":"2013","journal-title":"Neurobiol. Aging"},{"key":"B26","doi-asserted-by":"publisher","first-page":"189","DOI":"10.1038\/s43856-025-00904-9","article-title":"Rapamycin treatment for alzheimer's disease and related dementias: a pilot phase 1 clinical trial","volume":"5","author":"Gonzales","year":"2025","journal-title":"Commun. Med. (Lond)."},{"key":"B27","doi-asserted-by":"publisher","first-page":"251","DOI":"10.1038\/nrm3311","article-title":"AMPK: a nutrient and energy sensor that maintains energy homeostasis","volume":"13","author":"Hardie","year":"2012","journal-title":"Nat. Rev. Mol. Cell Biol."},{"key":"B28","doi-asserted-by":"publisher","first-page":"93","DOI":"10.1038\/nrm.2017.129","article-title":"Building and decoding ubiquitin chains for mitophagy","volume":"19","author":"Harper","year":"2018","journal-title":"Nat. Rev. Mol. Cell Biol."},{"key":"B29","doi-asserted-by":"publisher","first-page":"e71061","DOI":"10.1002\/alz.71061","article-title":"A blood based mitochondrial functional index biomarker for alzheimer's disease","volume":"21","author":"Hauger","year":"2025","journal-title":"Alzheimers Dement."},{"key":"B30","doi-asserted-by":"publisher","first-page":"4212","DOI":"10.1002\/alz.13847","article-title":"Urolithin A improves alzheimer's disease cognition and restores mitophagy and lysosomal functions","volume":"20","author":"Hou","year":"2024","journal-title":"Alzheimers Dement."},{"key":"B31","first-page":"539","article-title":"SS31 peptide improves the cognitive function of SAMP8 in rapidly aging mice and its related mechanism (in Chinese)","volume":"30","author":"Huo","year":"2022","journal-title":"J. Brain Nerv. Dis."},{"key":"B32","doi-asserted-by":"publisher","first-page":"216","DOI":"10.1038\/nature10821","article-title":"Probing sporadic and familial alzheimer's disease using induced pluripotent stem cells","volume":"482","author":"Israel","year":"2012","journal-title":"Nature"},{"key":"B33","doi-asserted-by":"publisher","first-page":"5","DOI":"10.1186\/s40035-026-00540-w","article-title":"Mitochondrial DNA: a molecular switch driving Sterile neuroinflammation","volume":"15","author":"Jauhari","year":"2026","journal-title":"Transl. Neurodegener."},{"key":"B34","doi-asserted-by":"publisher","first-page":"e174290","DOI":"10.1172\/jci.insight.174290","article-title":"Mitochondria-sequestered A\u03b2 renders synaptic mitochondria vulnerable in the elderly with a risk of alzheimer disease","volume":"8","author":"Jia","year":"","journal-title":"JCI Insight"},{"key":"B35","doi-asserted-by":"publisher","first-page":"36","DOI":"10.1016\/j.bbrc.2023.02.076","article-title":"The mitochondria-targeted small molecule SS31 delays progression of behavioral deficits by attenuating \u03b2-amyloid plaque formation and mitochondrial\/synaptic deterioration in APP\/PS1 mice","volume":"658","author":"Jia","year":"","journal-title":"Biochem. Biophys. Res. Commun."},{"key":"B36","doi-asserted-by":"publisher","first-page":"108043","DOI":"10.1016\/j.phrs.2025.108043","article-title":"Ginsenoside re binds Drp1 Leu94 across species to restore mitochondrial homeostasis via Atg1\/ULK1-dependent fission-mitophagy coupling in age-related degeneration","volume":"222","author":"Jin","year":"2025","journal-title":"Pharmacol. Res."},{"key":"B37","doi-asserted-by":"publisher","first-page":"149970","DOI":"10.1016\/j.brainres.2025.149970","article-title":"BNIP3L\/NIX-mediated mitophagy: future directions in alzheimer's disease","volume":"1867","author":"Kakoty","year":"2025","journal-title":"Brain Res."},{"key":"B38","doi-asserted-by":"publisher","first-page":"3052","DOI":"10.1016\/j.celrep.2017.03.008","article-title":"Neuroprotective functions for the histone deacetylase SIRT6","volume":"18","author":"Kaluski","year":"2017","journal-title":"Cell Rep."},{"key":"B39","doi-asserted-by":"publisher","first-page":"998","DOI":"10.4103\/1673-5374.385281","article-title":"Mitophagy in neurodegenerative disease pathogenesis","volume":"19","author":"Kan Yang","year":"2024","journal-title":"Neural Regen. Res."},{"key":"B40","doi-asserted-by":"publisher","first-page":"7075","DOI":"10.1007\/s12035-024-04632-4","article-title":"Mitochondrial alterations in alzheimer's disease: insight from the 5xFAD mouse model","volume":"62","author":"Keskinoz","year":"2025","journal-title":"Mol. Neurobiol."},{"key":"B41","doi-asserted-by":"publisher","first-page":"1283","DOI":"10.2174\/1567205014666170621111033","article-title":"Antioxidant SkQ1 alleviates signs of alzheimer's disease-like pathology in old OXYS rats by reversing mitochondrial deterioration","volume":"14","author":"Kolosova","year":"2017","journal-title":"Curr. Alzheimer Res."},{"key":"B42","doi-asserted-by":"publisher","DOI":"10.3791\/56768","article-title":"Generation of standardized and reproducible forebrain-type cerebral organoids from human induced pluripotent stem cells","volume":"131","author":"Krefft","year":"2018","journal-title":"J. Vis. Exp."},{"key":"B43","doi-asserted-by":"publisher","first-page":"350","DOI":"10.5607\/en.2018.27.5.350","article-title":"iPSC modeling of Presenilin1 mutation in alzheimer's disease with cerebellar ataxia","volume":"27","author":"Li","year":"2018","journal-title":"Exp. Neurobiol."},{"key":"B44","doi-asserted-by":"publisher","first-page":"387","DOI":"10.12182\/20210560501","article-title":"Mitochondrial DNA and cGAS-STING innate immune signaling pathway: latest research progress","volume":"52","author":"Li","year":"","journal-title":"Sichuan Da Xue Xue Bao Yi Xue Ban."},{"key":"B45","first-page":"13380","article-title":"Curcumin slows the progression of alzheimer's disease by modulating mitochondrial stress responses via JMJD3-H3K27me3-BDNF axis","volume":"13","author":"Li","year":"","journal-title":"Am. J. Transl. Res."},{"key":"B46","doi-asserted-by":"publisher","first-page":"248","DOI":"10.1186\/s12974-022-02613-9","article-title":"Mitochondrial dysfunction in microglia: a novel perspective for pathogenesis of alzheimer's disease","volume":"19","author":"Li","year":"2022","journal-title":"J. Neuroinflammation"},{"key":"B47","doi-asserted-by":"publisher","first-page":"360","DOI":"10.1038\/s41392-025-02453-y","article-title":"Microglia-derived nanovesicles synchronize macroautophagy and chaperone-mediated autophagy for alzheimer's disease therapy","volume":"10","author":"Li","year":"2025","journal-title":"Signal Transduct. Target Ther."},{"key":"B48","doi-asserted-by":"publisher","first-page":"223","DOI":"10.1016\/j.cell.2011.08.037","article-title":"Beclin1 controls the levels of p53 by regulating the deubiquitination activity of USP10 and USP13","volume":"147","author":"Liu","year":"2011","journal-title":"Cell"},{"key":"B49","doi-asserted-by":"publisher","first-page":"117","DOI":"10.1016\/j.jare.2021.02.003","article-title":"The heterogeneity among subgroups of haplogroup J influencing alzheimer's disease risk","volume":"33","author":"Liu","year":"","journal-title":"J. Adv. Res."},{"key":"B50","doi-asserted-by":"publisher","first-page":"3166","DOI":"10.1007\/s11064-021-03414-x","article-title":"Curcumin alleviates A\u03b2(42)-Induced neuronal metabolic dysfunction via the Thrb\/SIRT3 axis and improves cognition in APP(TG) mice","volume":"46","author":"Liu","year":"","journal-title":"Neurochem. Res."},{"key":"B51","doi-asserted-by":"publisher","first-page":"102697","DOI":"10.1016\/j.redox.2023.102697","article-title":"Acetylated tau exacerbates learning and memory impairment by disturbing with mitochondrial homeostasis","volume":"62","author":"Liu","year":"2023","journal-title":"Redox Biol."},{"key":"B52","doi-asserted-by":"publisher","first-page":"100158","DOI":"10.1016\/j.celbio.2025.100158","article-title":"Ceria-nanocluster based therapy for alzheimer's disease through the modulation of activated microglia and attenuation of amyloid-\u03b2 deposition","author":"Liu","year":"2025","journal-title":"Cell Biomater."},{"key":"B53","doi-asserted-by":"publisher","first-page":"1437","DOI":"10.1093\/hmg\/ddl066","article-title":"Mitochondria are a direct site of A beta accumulation in alzheimer's disease neurons: implications for free radical generation and oxidative damage in disease progression","volume":"15","author":"Manczak","year":"2006","journal-title":"Hum. Mol. Genet."},{"key":"B54","doi-asserted-by":"publisher","first-page":"2495","DOI":"10.1093\/hmg\/ddr139","article-title":"Impaired mitochondrial dynamics and abnormal interaction of amyloid beta with mitochondrial protein Drp1 in neurons from patients with alzheimer's disease: implications for neuronal damage","volume":"20","author":"Manczak","year":"2011","journal-title":"Hum. Mol. Genet."},{"key":"B55","doi-asserted-by":"publisher","first-page":"43449","DOI":"10.1038\/srep43449","article-title":"MtDNA meta-analysis reveals both phenotype specificity and allele heterogeneity: a model for differential association","volume":"7","author":"Marom","year":"2017","journal-title":"Sci. Rep."},{"key":"B56","doi-asserted-by":"publisher","first-page":"e00525","DOI":"10.1016\/j.neurot.2025.e00525","article-title":"Mitochondrial dysfunction in alzheimer's disease: guiding the path to targeted therapies","volume":"22","author":"McGill Percy","year":"2025","journal-title":"Neurotherapeutics"},{"key":"B57","doi-asserted-by":"publisher","first-page":"748388","DOI":"10.3389\/fnagi.2021.748388","article-title":"Mitochondrial deficits with neural and social damage in early-stage alzheimer's disease model mice","volume":"13","author":"Misrani","year":"2021","journal-title":"Front. Aging Neurosci."},{"key":"B58","doi-asserted-by":"publisher","first-page":"24","DOI":"10.1186\/s12951-026-04281-w","article-title":"Nanomaterials for alzheimer's disease: emerging strategies in diagnosis and therapy","volume":"24","author":"Na","year":"2026","journal-title":"J. Nanobiotechnology"},{"key":"B59","doi-asserted-by":"publisher","first-page":"43","DOI":"10.1093\/stmcls\/sxae091","article-title":"Senescence accelerated mouse-prone 8: a model of neuroinflammation and aging with features of sporadic alzheimer's disease","volume":"43","author":"Ong","year":"2025","journal-title":"Stem Cells"},{"key":"B60","doi-asserted-by":"publisher","first-page":"109013","DOI":"10.1016\/j.exer.2022.109013","article-title":"Differential mitochondrial and cellular responses between H vs. J mtDNA haplogroup-containing human RPE transmitochondrial cybrid cells","volume":"219","author":"Panvini","year":"2022","journal-title":"Exp. Eye Res."},{"key":"B61","doi-asserted-by":"publisher","first-page":"2977","DOI":"10.1007\/s11357-024-01118-y","article-title":"Mitochondrial disorders leading to Alzheimer's disease-perspectives of diagnosis and treatment","volume":"46","author":"Pszczo\u0142owska","year":"2024","journal-title":"Geroscience"},{"key":"B62","doi-asserted-by":"publisher","first-page":"e2408581","DOI":"10.1002\/smll.202408581","article-title":"The mitochondria-targeted micelle inhibits alzheimer's disease progression by alleviating neuronal mitochondrial dysfunction and neuroinflammation","volume":"21","author":"Qian","year":"2025","journal-title":"Small"},{"key":"B63","doi-asserted-by":"publisher","first-page":"3381","DOI":"10.16438\/j.0513-4870.2025-0511","article-title":"Research progress on the role and mechanisms of mitochondrial dysfunction in the pathogenesis of alzheimer's disease (in Chinese)","volume":"60","author":"Qin","year":"2025","journal-title":"Acta Pharmaceutica Sin."},{"key":"B64","doi-asserted-by":"publisher","first-page":"31372","DOI":"10.1155\/jbb\/2006\/31372","article-title":"Mitochondrial oxidative damage in aging and alzheimer's disease: implications for mitochondrially targeted antioxidant therapeutics","volume":"2006","author":"Reddy","year":"2006","journal-title":"J. Biomed. Biotechnol."},{"key":"B65","doi-asserted-by":"publisher","first-page":"e45134","DOI":"10.1371\/journal.pone.0045134","article-title":"Mitochondrial genomic analysis of late onset alzheimer's disease reveals protective haplogroups H6A1A\/H6A1B: the cache county study on memory in aging","volume":"7","author":"Ridge","year":"2012","journal-title":"PLoS One"},{"key":"B66","doi-asserted-by":"publisher","first-page":"161","DOI":"10.1016\/j.freeradbiomed.2009.10.039","article-title":"Consequences of long-term oral administration of the mitochondria-targeted antioxidant MitoQ to wild-type mice","volume":"48","author":"Rodriguez-Cuenca","year":"2010","journal-title":"Free Radic. Biol. Med."},{"key":"B67","doi-asserted-by":"publisher","first-page":"988","DOI":"10.1111\/jnc.15116","article-title":"Quantitative proteomic analysis of the frontal cortex in alzheimer's disease","volume":"156","author":"Sathe","year":"2021","journal-title":"J. Neurochem."},{"key":"B68","doi-asserted-by":"publisher","first-page":"6472","DOI":"10.1073\/pnas.0308686101","article-title":"The estrogen-related receptor alpha (ERRalpha) functions in PPARgamma coactivator 1alpha (PGC-1alpha)-induced mitochondrial biogenesis","volume":"101","author":"Schreiber","year":"2004","journal-title":"Proc. Natl. Acad. Sci. U. S. A."},{"key":"B69","doi-asserted-by":"publisher","first-page":"22","DOI":"10.3390\/ijms22115991","article-title":"An unbalanced synaptic transmission: cause or consequence of the amyloid oligomers neurotoxicity?","volume":"22","author":"Sciaccaluga","year":"2021","journal-title":"Int. J. Mol. Sci."},{"key":"B70","doi-asserted-by":"publisher","first-page":"401","DOI":"10.1016\/j.immuni.2012.01.009","article-title":"Oxidized mitochondrial DNA activates the NLRP3 inflammasome during apoptosis","volume":"36","author":"Shimada","year":"2012","journal-title":"Immunity"},{"key":"B71","doi-asserted-by":"publisher","first-page":"512","DOI":"10.1001\/jama.2023.13239","article-title":"Donanemab in early symptomatic alzheimer disease: the TRAILBLAZER-ALZ 2 randomized clinical trial","volume":"330","author":"Sims","year":"2023","journal-title":"Jama"},{"key":"B72","doi-asserted-by":"publisher","first-page":"266","DOI":"10.1016\/j.jagp.2017.10.010","article-title":"Memory and brain amyloid and tau effects of a bioavailable form of curcumin in non-demented adults: a double-blind, placebo-controlled 18-Month trial","volume":"26","author":"Small","year":"2018","journal-title":"Am. J. Geriatr. Psychiatry"},{"key":"B73","doi-asserted-by":"publisher","first-page":"1670","DOI":"10.1002\/mds.23148","article-title":"A double-blind, placebo-controlled study to assess the mitochondria-targeted antioxidant MitoQ as a disease-modifying therapy in parkinson's disease","volume":"25","author":"Snow","year":"2010","journal-title":"Mov. Disord."},{"key":"B74","doi-asserted-by":"publisher","first-page":"681","DOI":"10.3233\/jad-131034","article-title":"Alzheimer's disease-like pathology in senescence-accelerated OXYS rats can be partially retarded with mitochondria-targeted antioxidant SkQ1","volume":"38","author":"Stefanova","year":"2014","journal-title":"J. Alzheimers Dis."},{"key":"B75","doi-asserted-by":"publisher","first-page":"3984906","DOI":"10.1155\/2019\/3984906","article-title":"Suppression of alzheimer's disease-like pathology progression by mitochondria-targeted antioxidant SkQ1: a transcriptome profiling study","volume":"2019","author":"Stefanova","year":"2019","journal-title":"Oxid. Med. Cell Longev."},{"key":"B76","doi-asserted-by":"publisher","first-page":"12","DOI":"10.3390\/cells12071006","article-title":"The beneficial effect of mitochondrial transfer therapy in 5XFAD mice via liver-serum-brain response","volume":"12","author":"Sweetat","year":"2023","journal-title":"Cells"},{"key":"B77","doi-asserted-by":"publisher","first-page":"8","DOI":"10.1016\/j.mehy.2003.12.045","article-title":"A \u201cmitochondrial cascade hypothesis\u201d for sporadic alzheimer\u2019s disease","volume":"63","author":"Swerdlow","year":"2004","journal-title":"Med. Hypotheses"},{"key":"B78","doi-asserted-by":"publisher","first-page":"12","DOI":"10.3390\/antiox12030631","article-title":"24-Hydroxycholesterol induces tau proteasome-dependent degradation via the SIRT1\/PGC1\u03b1\/Nrf2 pathway: a potential mechanism to counteract alzheimer's disease","volume":"12","author":"Testa","year":"2023","journal-title":"Antioxidants (Basel)"},{"key":"B79","doi-asserted-by":"publisher","first-page":"e55678","DOI":"10.15252\/embr.202255678","article-title":"Modeling mitochondrial DNA diseases: from base editing to pluripotent stem-cell-derived organoids","volume":"24","author":"Tolle","year":"2023","journal-title":"EMBO Rep."},{"key":"B80","doi-asserted-by":"publisher","first-page":"1383","DOI":"10.1212\/wnl.0000000000002035","article-title":"A randomized, double-blind, placebo-controlled trial of resveratrol for alzheimer disease","volume":"85","author":"Turner","year":"2015","journal-title":"Neurology"},{"key":"B81","doi-asserted-by":"publisher","first-page":"9","DOI":"10.1056\/NEJMoa2212948","article-title":"Lecanemab in early alzheimer's disease","volume":"388","author":"van Dyck","year":"2023","journal-title":"N. Engl. J. Med."},{"key":"B82","doi-asserted-by":"publisher","first-page":"33","DOI":"10.3233\/jad-181043","article-title":"Therapeutic potential of AMP-activated protein kinase in alzheimer's disease","volume":"68","author":"Wang","year":"2019","journal-title":"J. Alzheimers Dis."},{"key":"B83","doi-asserted-by":"publisher","first-page":"304","DOI":"10.1038\/s41392-023-01503-7","article-title":"The mitophagy pathway and its implications in human diseases","volume":"8","author":"Wang","year":"2023","journal-title":"Signal Transduct. Target Ther."},{"key":"B84","doi-asserted-by":"publisher","first-page":"1484373","DOI":"10.3389\/fimmu.2024.1484373","article-title":"Mitochondrial dysfunction in alzheimer's disease: a key frontier for future targeted therapies","volume":"15","author":"Wang","year":"2024","journal-title":"Front. Immunol."},{"key":"B85","doi-asserted-by":"publisher","first-page":"2966","DOI":"10.1016\/j.apsb.2025.04.019","article-title":"Structures and functions of the MICOS: pathogenesis and therapeutic implications in alzheimer's disease","volume":"15","author":"Wang","year":"","journal-title":"Acta Pharm. Sin. B"},{"key":"B86","doi-asserted-by":"publisher","first-page":"5179","DOI":"10.1038\/s41467-025-60315-1","article-title":"An AI-assisted fluorescence microscopic system for screening mitophagy inducers by simultaneous analysis of mitophagic intermediates","volume":"16","author":"Wang","year":"","journal-title":"Nat. Commun."},{"key":"B87","doi-asserted-by":"publisher","first-page":"100874","DOI":"10.1016\/j.cophys.2025.100874","article-title":"Unlocking therapies for neurodegeneration: targeting mitochondrial dysfunction and oxidative stress in Alzheimer\u2019s disease","volume":"47","author":"Wong","year":"2026","journal-title":"Curr. Opin. Physiology"},{"key":"B88","doi-asserted-by":"publisher","first-page":"76","DOI":"10.1038\/s41551-021-00819-5","article-title":"Amelioration of alzheimer's disease pathology by mitophagy inducers identified via machine learning and a cross-species workflow","volume":"6","author":"Xie","year":"2022","journal-title":"Nat. Biomed. Eng."},{"key":"B89","doi-asserted-by":"publisher","first-page":"2655","DOI":"10.1080\/15548627.2024.2383145","article-title":"Spautin-1 promotes PINK1-PRKN-dependent mitophagy and improves associative learning capability in an alzheimer disease animal model","volume":"20","author":"Yi","year":"2024","journal-title":"Autophagy"},{"key":"B90","doi-asserted-by":"publisher","first-page":"2524832","DOI":"10.1155\/2022\/2524832","article-title":"Rhein ameliorates cognitive impairment in an APP\/PS1 transgenic mouse model of alzheimer's disease by relieving oxidative stress through activating the SIRT1\/PGC-1\u03b1 pathway","volume":"2022","author":"Yin","year":"2022","journal-title":"Oxid. Med. Cell Longev."},{"key":"B91","doi-asserted-by":"publisher","first-page":"103409","DOI":"10.1016\/j.mcn.2019.103409","article-title":"The mitochondria-targeted antioxidant MitoQ inhibits memory loss, neuropathology, and extends lifespan in aged 3xTg-AD mice","volume":"101","author":"Young","year":"2019","journal-title":"Mol. Cell Neurosci."},{"key":"B92","doi-asserted-by":"publisher","first-page":"e70839","DOI":"10.1002\/alz.70839","article-title":"Mitochondrial haplogroups, but not heteroplasmy, are associated with midlife cognitive function","volume":"21","author":"Yu","year":"2025","journal-title":"Alzheimers Dement."},{"key":"B93","doi-asserted-by":"publisher","first-page":"e2204596","DOI":"10.1002\/advs.202204596","article-title":"Nano-brake halts mitochondrial dysfunction Cascade to alleviate neuropathology and rescue alzheimer's cognitive deficits","volume":"10","author":"Zhang","year":"2023","journal-title":"Adv. Sci. (Weinh)"},{"key":"B94","doi-asserted-by":"publisher","first-page":"1542","DOI":"10.6039\/j.issn.1001-0408.2025.12.22","article-title":"Research progress on mechanism of traditional Chinese medicine in improving myocardial ischemiareperfusion injury by mitochondrial quality control (in Chinese)","volume":"36","author":"Zhang","year":"2025","journal-title":"China Pharm."},{"key":"B95","doi-asserted-by":"publisher","first-page":"3285","DOI":"10.4103\/nrr.Nrr-d-25-00367","article-title":"cGAS-STING axis: a central regulator of neural homeostasis and neuroinflammatory pathogenesis","volume":"21","author":"Zhang","year":"2026","journal-title":"Neural Regen. Res."},{"key":"B96","doi-asserted-by":"publisher","first-page":"121690","DOI":"10.1016\/j.biomaterials.2022.121690","article-title":"Blood-brain barrier permeable nanoparticles for alzheimer's disease treatment by selective mitophagy of microglia","volume":"288","author":"Zhong","year":"2022","journal-title":"Biomaterials"}],"container-title":["Frontiers in Cell and Developmental Biology"],"original-title":[],"link":[{"URL":"https:\/\/www.frontiersin.org\/articles\/10.3389\/fcell.2026.1886145\/full","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,8,27]],"date-time":"2026-08-27T11:02:46Z","timestamp":1787828566000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.frontiersin.org\/articles\/10.3389\/fcell.2026.1886145\/full"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,8,27]]},"references-count":96,"alternative-id":["10.3389\/fcell.2026.1886145"],"URL":"https:\/\/doi.org\/10.3389\/fcell.2026.1886145","relation":{},"ISSN":["2296-634X"],"issn-type":[{"value":"2296-634X","type":"electronic"}],"subject":[],"published":{"date-parts":[[2026,8,27]]},"article-number":"1886145"}}